open access

Vol 56, No 4 (2022)
Research Paper
Submitted: 2021-10-21
Accepted: 2022-02-07
Published online: 2022-04-26
Get Citation

Diagnostic value of diffusion tensor imaging in patients with clinical signs of cervical spondylotic myelopathy

Monika Skotarczak1, Jarosław Dzierżanowski2, Mariusz Kaszubowski3, Paweł J. Winklewski45, Alexander Romanowski6, Edyta Szurowska1, Arkadiusz Szarmach1
·
Pubmed: 35471632
·
Neurol Neurochir Pol 2022;56(4):341-348.
Affiliations
  1. 2nd Department of Radiology, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland
  2. Department of Neurosurgery, Faculty of Medicine, Medical University of Gdansk, Poland
  3. Department of Economic Sciences, Faculty of Management and Economics, Gdansk University of Technology, Gdansk, Poland
  4. Department of Human Physiology, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland
  5. Department of Clinical Anatomy and Physiology, Faculty of Health Sciences, Pomeranian University of Slupsk, Slupsk, Poland
  6. Department of Psychiatry and Psychotherapy, Helios Clinic Hettstedt, Germany

open access

Vol 56, No 4 (2022)
Research papers
Submitted: 2021-10-21
Accepted: 2022-02-07
Published online: 2022-04-26

Abstract

Aim of the study. The aim of this study was to assess the diagnostic value of diffusion tensor imaging (DTI) in patients with symptoms of cervical myelopathy. Detailed goals included determining the diagnostic effectiveness of quantitative parameters, i.e. fractional anisotropy (FA) and apparent diffusion coefficient (ADC), in the diagnosis of cervical myelopathy, and the correlation between these parameters and clinical symptoms.

Clinical rationale for the study. The demonstration of an ischaemic focus in the spinal cord by standard magnetic resonance imaging (MRI) methods is associated with already accomplished spinal cord damage, and of course limited treatment options. Therefore, finding a new examination protocol that allows early diagnosis of myelopathic focus, before the onset of full neurological symptoms, has become a priority in the diagnosis and treatment of spine diseases. Such an examination increases the chances of correctly qualifying the patient for conservative vs. surgical treatment.

Material and methods. Between 2013 and 2017, 128 adults with clinical signs of cervical myelopathy were examined, and were divided into four symptomatic subgroups. A control group consisted of 37 healthy volunteers. DTI values were measured at the level of C2/C3, and at the most severe stenosis of the spine.

Results. In patients with cervical spondylotic myelopathy (CSM), the ADC values were significantly higher (p < 0.001), and FA values were significantly lower (p < 0.001), than in healthy volunteers at the stenotic level. There were significant differences in DTI parameters between the clinical subgroups (p < 0.001).

Conclusions and clinical implications. Changes in DTI parameters indicate a microstructural disorder of the core which is not visible in a structural MRI. FA and ADC values measured at the level of the most severe stenosis of the spinal canal allow the differentiation of patients with myelopathy of varying degrees of clinical severity. Extending standard MRI to include assessment of FA and ADC may be helpful in deciding treatment modalities (conservative vs. surgical) for patients with visible canal stenosis without full neurological symptoms. This may be useful in selecting patients for urgent rehabilitative treatment. This study is a starting point for further research, i.e. an evaluation of the extent of FA and ADC lesion withdrawal after surgical treatment.

Abstract

Aim of the study. The aim of this study was to assess the diagnostic value of diffusion tensor imaging (DTI) in patients with symptoms of cervical myelopathy. Detailed goals included determining the diagnostic effectiveness of quantitative parameters, i.e. fractional anisotropy (FA) and apparent diffusion coefficient (ADC), in the diagnosis of cervical myelopathy, and the correlation between these parameters and clinical symptoms.

Clinical rationale for the study. The demonstration of an ischaemic focus in the spinal cord by standard magnetic resonance imaging (MRI) methods is associated with already accomplished spinal cord damage, and of course limited treatment options. Therefore, finding a new examination protocol that allows early diagnosis of myelopathic focus, before the onset of full neurological symptoms, has become a priority in the diagnosis and treatment of spine diseases. Such an examination increases the chances of correctly qualifying the patient for conservative vs. surgical treatment.

Material and methods. Between 2013 and 2017, 128 adults with clinical signs of cervical myelopathy were examined, and were divided into four symptomatic subgroups. A control group consisted of 37 healthy volunteers. DTI values were measured at the level of C2/C3, and at the most severe stenosis of the spine.

Results. In patients with cervical spondylotic myelopathy (CSM), the ADC values were significantly higher (p < 0.001), and FA values were significantly lower (p < 0.001), than in healthy volunteers at the stenotic level. There were significant differences in DTI parameters between the clinical subgroups (p < 0.001).

Conclusions and clinical implications. Changes in DTI parameters indicate a microstructural disorder of the core which is not visible in a structural MRI. FA and ADC values measured at the level of the most severe stenosis of the spinal canal allow the differentiation of patients with myelopathy of varying degrees of clinical severity. Extending standard MRI to include assessment of FA and ADC may be helpful in deciding treatment modalities (conservative vs. surgical) for patients with visible canal stenosis without full neurological symptoms. This may be useful in selecting patients for urgent rehabilitative treatment. This study is a starting point for further research, i.e. an evaluation of the extent of FA and ADC lesion withdrawal after surgical treatment.

Get Citation

Keywords

cervical spondylotic myelopathy, magnetic resonance imaging, diffusion tensor imaging, spinal canal stenosis

About this article
Title

Diagnostic value of diffusion tensor imaging in patients with clinical signs of cervical spondylotic myelopathy

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 56, No 4 (2022)

Article type

Research Paper

Pages

341-348

Published online

2022-04-26

Page views

4414

Article views/downloads

630

DOI

10.5603/PJNNS.a2022.0031

Pubmed

35471632

Bibliographic record

Neurol Neurochir Pol 2022;56(4):341-348.

Keywords

cervical spondylotic myelopathy
magnetic resonance imaging
diffusion tensor imaging
spinal canal stenosis

Authors

Monika Skotarczak
Jarosław Dzierżanowski
Mariusz Kaszubowski
Paweł J. Winklewski
Alexander Romanowski
Edyta Szurowska
Arkadiusz Szarmach

References (45)
  1. Morio Y, Yamamoto K, Kuranobu K, et al. Does increased signal intensity of the spinal cord on MR images due to cervical myelopathy predict prognosis? Arch Orthop Trauma Surg. 1994; 113(5): 254–259.
  2. Jones JGA, Cen SY, Lebel RM, et al. Diffusion tensor imaging correlates with the clinical assessment of disease severity in cervical spondylotic myelopathy and predicts outcome following surgery. AJNR Am J Neuroradiol. 2013; 34(2): 471–478.
  3. Wen CYi, Cui JL, Liu HS, et al. Is diffusion anisotropy a biomarker for disease severity and surgical prognosis of cervical spondylotic myelopathy? Radiology. 2014; 270(1): 197–204.
  4. Vedantam A, Rajshekhar V. Does the type of T2-weighted hyperintensity influence surgical outcome in patients with cervical spondylotic myelopathy? A review. Eur Spine J. 2013; 22(1): 96–106.
  5. Kerkovský M, Bednarík J, Dušek L, et al. Magnetic resonance diffusion tensor imaging in patients with cervical spondylotic spinal cord compression: correlations between clinical and electrophysiological findings. Spine (Phila Pa 1976). 2012; 37(1): 48–56.
  6. Radek M, Wiśniewski K, Grochal M, et al. [Spinal cord diffusion tensor tractography as a diagnostic tool in difficult cases of spinal cord intramedullary tumours]. Neurol Neurochir Pol. 2013; 47(1): 74–79.
  7. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001; 13(4): 534–546.
  8. Basser PJ, Pierpaoli C, Basser PJ, et al. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994; 66(1): 259–267.
  9. Thurnher M, Law M. Diffusion-Weighted imaging, diffusion-tensor imaging, and fiber tractography of the spinal cord. Magn Reson Imaging Clin N Am. 2009; 17(2): 225–244.
  10. Vedantam A, Jirjis MB, Schmit BD, et al. Diffusion tensor imaging of the spinal cord: insights from animal and human studies. Neurosurgery. 2014; 74(1): 1–8; discussion 8; quiz 8.
  11. Rajasekaran S, Kanna RM, Shetty AP. Diffusion tensor imaging of the spinal cord and its clinical applications. J Bone Joint Surg Br. 2012; 94(8): 1024–1031.
  12. Szmuda T, Słoniewski P, Ali S, et al. Reliability of diffusion tensor tractography of facial nerve in cerebello-pontine angle tumours. Neurol Neurochir Pol. 2020; 54(1): 73–82.
  13. Lee JW, Kim JH, Park JB, et al. Diffusion tensor imaging and fiber tractography in cervical compressive myelopathy: preliminary results. Skeletal Radiol. 2011; 40(12): 1543–1551.
  14. Budzik JF, Balbi V, Le Thuc V, et al. Diffusion tensor imaging and fibre tracking in cervical spondylotic myelopathy. Eur Radiol. 2011; 21(2): 426–433.
  15. Demir A, Ries M, Moonen CTW, et al. Diffusion-weighted MR imaging with apparent diffusion coefficient and apparent diffusion tensor maps in cervical spondylotic myelopathy. Radiology. 2003; 229(1): 37–43.
  16. Song T, Chen WJ, Yang Bo, et al. Diffusion tensor imaging in the cervical spinal cord. Eur Spine J. 2011; 20(3): 422–428.
  17. Wang W, Qin W, Hao N, et al. Diffusion tensor imaging in spinal cord compression. Acta Radiol. 2012; 53(8): 921–928.
  18. Demir A, Ries M, Moonen CTW, et al. Diffusion-weighted MR imaging with apparent diffusion coefficient and apparent diffusion tensor maps in cervical spondylotic myelopathy. Radiology. 2003; 229(1): 37–43.
  19. Xiangshui M, Xiangjun C, Xiaoming Z, et al. 3 T magnetic resonance diffusion tensor imaging and fibre tracking in cervical myelopathy. Clin Radiol. 2010; 65(6): 465–473.
  20. Mamata H, Jolesz FA, Maier SE. Apparent diffusion coefficient and fractional anisotropy in spinal cord: age and cervical spondylosis-related changes. J Magn Reson Imaging. 2005; 22(1): 38–43.
  21. Gao SJ, Yuan X, Jiang XY, et al. Correlation study of 3T-MR-DTI measurements and clinical symptoms of cervical spondylotic myelopathy. Eur J Radiol. 2013; 82(11): 1940–1945.
  22. Yoo WK, Kim TH, Hai DM, et al. Correlation of magnetic resonance diffusion tensor imaging and clinical findings of cervical myelopathy. Spine J. 2013; 13(8): 867–876.
  23. Budzik JF, Balbi V, Le Thuc V, et al. Diffusion tensor imaging and fibre tracking in cervical spondylotic myelopathy. Eur Radiol. 2011; 21(2): 426–433.
  24. Wang K, Chen Z, Zhang F, et al. Evaluation of DTI parameter ratios and diffusion tensor tractography grading in the diagnosis and prognosis prediction of cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2017; 42(4): E202–E210.
  25. Ying J, Zhou X, Zhu M, et al. The contribution of diffusion tensor imaging to quantitative assessment on multilevel cervical spondylotic myelopathy. Eur Neurol. 2016; 75(1-2): 67–74.
  26. Rajasekaran S, Yerramshetty JS, Chittode VS, et al. The assessment of neuronal status in normal and cervical spondylotic myelopathy using diffusion tensor imaging. Spine (Phila Pa 1976). 2014; 39(15): 1183–1189.
  27. Chen X, Kong C, Feng S, et al. Magnetic resonance diffusion tensor imaging of cervical spinal cord and lumbosacral enlargement in patients with cervical spondylotic myelopathy. J Magn Reson Imaging. 2016; 43(6): 1484–1491.
  28. Limanówka B, Sagan L. Changes in cervical range of motion following anterior cervical discectomy with fusion - preliminary results. Neurol Neurochir Pol. 2020; 54(6): 568–575.
  29. Zapolska G, Kwiatkowski M, Turek G, et al. Biomechanical evaluation of single- and multi-level anterior cervical discectomy and fusion with polyetheretherketone cages: radiological and clinical outcomes. Neurol Neurochir Pol. 2019; 53(5): 358–362.
  30. Feng S, Zheng B, Zhang Li, et al. A systematic review and meta-analysis compare surgical treatment and conservative treatment in patients with cervical spondylotic myelopathy. Ann Palliat Med. 2021; 10(7): 7671–7680.
  31. Sampath P, Bendebba M, Davis JD, et al. Outcome of patients treated for cervical myelopathy. A prospective, multicenter study with independent clinical review. Spine (Phila Pa 1976). 2000; 25(6): 670–676.
  32. Bond M, McIntosh G, Fisher C, et al. Canadian Spine Outcomes and Research Network (CSORN) group. Treatment of mild cervical myelopathy: factors associated with decision for surgical intervention. Spine (Phila Pa 1976). 2019; 44(22): 1606–1612.
  33. Fehlings MG, Tetreault LA, Riew KD, et al. A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression. Global Spine J. 2017; 7(3 Suppl): 70S–83S.
  34. Sąsiadek MJ, Szewczyk P, Bladowska J. Application of diffusion tensor imaging (DTI) in pathological changes of the spinal cord. Med Sci Monit. 2012; 18(6): RA73–RA79.
  35. Kerkovský M, Bednarík J, Dušek L, et al. Magnetic resonance diffusion tensor imaging in patients with cervical spondylotic spinal cord compression: correlations between clinical and electrophysiological findings. Spine (Phila Pa 1976). 2012; 37(1): 48–56.
  36. Facon D, Ozanne A, Fillard P, et al. MR diffusion tensor imaging and fiber tracking in spinal cord compression. AJNR Am J Neuroradiol. 2005; 26(6): 1587–1594.
  37. Kara B, Celik A, Karadereler S, et al. The role of DTI in early detection of cervical spondylotic myelopathy: a preliminary study with 3-T MRI. Neuroradiology. 2011; 53(8): 609–616.
  38. Toktas ZO, Tanrıkulu B, Koban O, et al. Diffusion tensor imaging of cervical spinal cord: A quantitative diagnostic tool in cervical spondylotic myelopathy. J Craniovertebr Junction Spine. 2016; 7(1): 26–30.
  39. Chagawa K, Nishijima S, Kanchiku T, et al. Normal values of diffusion tensor magnetic resonance imaging parameters in the cervical spinal cord. Asian Spine J. 2015; 9(4): 541–547.
  40. Wei LF, Wang SS, Zheng ZC, et al. Analysis of the diffusion tensor imaging parameters of a normal cervical spinal cord in a healthy population. J Spinal Cord Med. 2017; 40(3): 338–345.
  41. Wang K, Song Q, Zhang F, et al. Age-related changes of the diffusion tensor imaging parameters of the normal cervical spinal cord. Eur J Radiol. 2014; 83(12): 2196–2202.
  42. Maier SE, Mamata H. Diffusion tensor imaging of the spinal cord. Ann N Y Acad Sci. 2005; 1064: 50–60.
  43. Vedantam A, Jirjis MB, Schmit BD, et al. Characterization and limitations of diffusion tensor imaging metrics in the cervical spinal cord in neurologically intact subjects. J Magn Reson Imaging. 2013; 38(4): 861–867.
  44. Ellingson BM, Ulmer JL, Kurpad SN, et al. Diffusion Tensor MR Imaging of the Neurologically Intact Human Spinal Cord. American Journal of Neuroradiology. 2008; 29(7): 1279–1284.
  45. Ellingson BM, Salamon N, Grinstead JW, et al. Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy. Spine J. 2014; 14(11): 2589–2597.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl